Orchid Pharma Balance Sheet
- Market cap
- ₹4,933 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹700.31 – ₹1,313.08
As of FY25, Orchid Pharma had total assets of ₹3,207 crore and borrowings of ₹592 crore, against shareholders' equity of ₹2,340 crore — a debt-to-equity ratio of 0.35.
Orchid Pharma balance sheet
As at each financial year end, newest first. H1 = half-year.
| Item | FY25 |
|---|---|
| Equity capital | 120 |
| Reserves | 2,220 |
| Borrowings | 592 |
| Other liabilities | 395 |
| Total liabilities | 3,207 |
| Fixed assets | 1,727 |
| Capital work in progress | 45 |
| Investments | 740 |
| Other assets | 740 |
| Total assets | 3,207 |
Balance sheet ratios
- Debt to equity
- 0.35
- Book value per share
- ₹341.28
Source: Company filings (consolidated), in ₹ crore. Data as of 9 October 2026. How this data is compiled.
Orchid Pharma balance sheet — frequently asked questions
What is the total debt of Orchid Pharma?
Orchid Pharma reported borrowings of ₹592 crore as of FY25.
What is Orchid Pharma's debt-to-equity ratio?
Based on the FY25 balance sheet, Orchid Pharma's debt-to-equity ratio is 0.35 — borrowings of ₹592 crore against equity capital and reserves of ₹2,340 crore.
What are Orchid Pharma's total assets?
Orchid Pharma's total assets were ₹3,207 crore as of FY25, including fixed assets of ₹1,727 crore and investments of ₹740 crore.
What is the book value per share of Orchid Pharma?
The book value per share of Orchid Pharma is ₹341.28, based on the latest reported balance sheet.
Same Data For Peers
Trade Orchid Pharma With ATS
Track ORCHPHARMA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.